Abstract
This chapter deals with one aspect of the topic of drug interactions, and contains a discussion of the problem from a physicochemical viewpoint. Many drug interactions in vitro are, not surprisingly, readily explained by resorting to the physical chemistry discussed in previous chapters of this book. There is no reason why the same forces and phenomena that operate in vitro cannot explain many of the observed interactions that occur in vivo, although of course the interplay of physicochemical and physiological forces makes simple interpretations a little hazardous. Interactions such as protein binding, whether as a result of hydrophobic or electrostatic interactions, adsorption of drugs onto solids, chelation and complexation all occur in physiological conditions and are predictable to a large degree.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
M. Edward. Am. J. hosp. Pharm., 24, 440 (1967)
C.L.J. Coles and K.A. Lees. Pharm. J., 206, 153 (1971)
B. Lynn. ibid, 154 (1971)
W. Jusko, M. Gretch and R. Gassett. J. am. med. Ass., 225, 176 (1973)
S.H. Yalkowsky and S.G. Valvani. Drug Intell. clin. Pharm., 11, 417 (1977)
J.B. Crapper. Br. med. J., 1, 33 (1975)
T.R. Marshall, J.T. Ling, G. Follis and M. Russell. Radiology, 84, 536 (1965)
M.A. El-Nakeeb. Acta pharm. suec., 5, 1 (1968)
G.M. Irvin, H.B. Kostenbauder et al. J. pharm. Sci., 58, 313 (1969)
A.C. Barbara, C. Clemente and E. Wagman. New Engl. J. Med., 274, 1316 (1966)
P.R. Clink and J.L. Colaizzi. J. pharm. Sci., 62, 97 (1973)
J.T. Doluisio and A.N. Martin. J. med. Chem., 6, 16 (1963)
A.E. Mahgoub, E.M. Khairy and A. Kasem. J. pharm. Sci., 63, 1451 (1974)
W. Kohn. Anal. Chem., 33, 862 (1962)
A.E. Martell and M. Calvin. Chemistry of the Metal Chelate Compound. Prentice-Hall, New York, 1952, p. 54.
J.J. Ambre and L.T. Fischer. Clin. Pharmac. Ther., 14, 231 (1973)
M.A. Zoglio. J. pharm. Sci., 58, 222 (1969)
L. Gross and M. Brotman. Ann. intern. Med., 72, 95 (1970)
A. Coronato and G.R.J. Glass. Proc. exp. Biol. Med., 142, 1341 (1973)
S.A.H. Khalil and M.A. Moustafa. Pharmazie, 28, 116 (1972)
G. Boman, P. Lundgren and G. Stjernstrom. Eur. J. clin. Pharmac., 8, 293 (1975)
T.J. McCarthy. J. mond. Pharm., 12, 321 (1969)
E.G. Beveridge and I.A. Hope. Pharm. J., 198, 457 (1967)
S.A.H. Khalil and R.N. Nasipuri. J. Pharm. Pharmac., 25, 138 (1973)
S. El-Masry and S.A.H. Khalil. ibid, 26, 243 (1974)
J. Dony and J. Conter. J. Pharm. belg., 11, 338 (1956)
C. Trolle-Lassen. Arch. pharm. Chem., 67, 504 (1960)
I. Moriguchi and N. Kaneniwa. Chem. pharm. Bull., 17, 394 (1969)
S.J. Meldrum et al. Br. med. J., 2, 104 (1972)
A.J. Fairfax, J. Adam and F.S. Pagan. Br. med. J., 1, 820 (1978)
G. Levy and Hayes. New Engl. J. Med., 262, 1053 (1960)
J.H. Lipton. New Engl. J. Med., 268, 92 (1963)
D.E. Langdon et al. J. am. med. Ass., 223, 184 (1973)
L.R. Peterson and D.N. Gerding. Lancet, 2, 376 (1978)
E.J. Lien, J. Kuwahara and R.T. Koda. Drug Intell. clin. Pharm., 8, 470 (1974)
K.J. Keda. Chem. pharm. Bull., 23, 201 (1975)
K.J. Keda. J. Pharm. Sci., 63, 1168 (1974)
D.E. Tutt and M.A. Schwartz. J. am. chem. Soc., 93, 767 (1971)
Further reading
L.E. Cluff and J.C. Petrie (eds.). Clinical Effects of Interactions between Drugs, Excerpta Medica, Amsterdam, 1974, chapters 5 and 6
J.P. Griffin and P.F. D’Arcy. A Manual of Adverse Drug Interactions, Wright, Bristol, 1975, pp. 3–53
Author information
Authors and Affiliations
Copyright information
© 1981 A.T. Florence and D. Attwood
About this chapter
Cite this chapter
Florence, A.T., Attwood, D. (1981). Drug Interactions and Incompatibilities — a physicochemical viewpoint. In: Physicochemical Principles of Pharmacy. Palgrave, London. https://doi.org/10.1007/978-1-349-19480-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-349-19480-3_10
Publisher Name: Palgrave, London
Print ISBN: 978-0-333-44996-7
Online ISBN: 978-1-349-19480-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)